Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-249233
Filing Date
2024-11-01
Accepted
2024-11-01 08:01:29
Documents
1
Effectiveness Date
2024-11-01

Document Format Files

Seq Description Document Type Size
1 S-8 POS d86674ds8pos.htm S-8 POS 19712
  Complete submission text file 0001193125-24-249233.txt   20794
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

EIN.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-254773 | Film No.: 241417111
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)